Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002001011-25-000016
Filing Date
2025-03-06
Accepted
2025-03-06 18:55:43
Documents
1
Period of Report
2025-03-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5721
  Complete submission text file 0002001011-25-000016.txt   7239
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIGAND PHARMACEUTICALS INCORPORATED 3911 SORRENTO VALLEY BLVD, SUITE 110 SAN DIEGO CA 92121
Business Address
Reardon Andrew (Reporting) CIK: 0001950232 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 25716824